Fig 1.
Flow diagram of the study population.
Table 1.
Sociodemographic characteristic of the study population.
Table 2.
Baseline clinical characteristic of the study population.
Fig 2.
Prevalence of metabolic syndrome (MetS) in hard-to-treat psoriasis.
Fig 3.
Psoriatic lesion in some of the hard-to-treat areas of the study population.
Face and scalp (a), palmoplantar (b, c), nails (d), and inframammary folds/intertriginous (e). *Archives of the Dermato-Allergo-Immunology Division, Department of Dermatology & Venereology FMUI/CMH.
Table 3.
Association of metabolic syndrome and psoriasis severity.
Table 4.
Association of metabolic syndrome components and HbA1c level with hard-to-treat psoriasis severity.
Fig 4.
Comparative analysis and distribution of triglycerides, HDL, fasting blood glucose, and HbA1c level between PASI score more than 10 and below 10.
(Δ, ◊ individuals data from each groups; l median).